Sort
59,101 grants matching “hypertension”
Use Of Animal Models To Study Lipid Genes That Modulate Atherosclerosis
$2,559,154Alan Remaley · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Pulmonary Hypertension Breakthrough Initiative
$2,557,971Mark W Geraci · University Of Colorado Denver · R24 · FY2014 · HL
The Virtual Physiological Rat Project
$2,557,339Daniel A Beard · Medical College Of Wisconsin · P50 · FY2012 · GM
Vascular Subphenotypes of Lung Disease
$2,556,023Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · HL
A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
$2,555,013Rebecca Gersnoviez Clifton · George Washington University · U01 · FY2024 · HD
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,554,475Shruti H Mehta · Johns Hopkins University · U01 · FY2019 · DA
GENERAL CLINICAL RESEARCH CENTER
$2,552,313Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2006 · RR
Continuation of the NuMoM2b Heart Health Study
$2,550,754Rebecca Boehm McNeil · Research Triangle Institute · U01 · FY2021 · HL
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$2,550,443Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2024 · HL
Impact of SARS-CoV-2 on the cerebrovasculature as a risk factor for VCID: Role of Wnt/beta-catenin
$2,549,080Sarah Elizabeth Lutz · University Of Illinois At Chicago · RF1 · FY2025 · NS
Study/Women/Health Across Nation III/Coordinating Center
$2,548,729University Of Pittsburgh At Pittsburgh · U01 · FY2004 · AG
Pharmacogenetics Network For Cardiovascular Risk Therapy
$2,538,048University Of Calif-Lawrenc Berkeley Lab · U01 · FY2001 · HL
Integrative Consequences of Intermittent Hypoxia
$2,534,438Nanduri R Prabhakar · University Of Chicago · P01 · FY2019 · HL
TAS::75 0872::TAS PROTEOMICS OF INFLAMMATION, IMNUNITY AND PULMONARY ARTERIAL HY
$2,533,866Garry P Nolan · Stanford University · N01 · FY2010 · HL
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacks
$2,531,399Korey Kam · Icahn School Of Medicine At Mount Sinai · RF1 · FY2023 · AG
Aging as a Risk Factor and Target for Prevention of Liver Cancer
$2,531,382Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
Aging as a Risk Factor and Target for Prevention of Liver Cancer
$2,530,091Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research
$2,529,652Jorge Eduardo Chavarro · Harvard School Of Public Health · U01 · FY2021 · HL
Risk Factors for Breast Cancer in Younger Nurses
$2,526,236Walter C. Willett · Harvard School Of Public Health · R01 · FY2012 · CA
SCOR MOLECULAR GENETICS OF HYPERTENSION
$2,522,404Brigham And Women'S Hospital · P50 · FY2004 · HL
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,521,954Shruti H Mehta · Johns Hopkins University · U01 · FY2020 · DA
Genetic Epidemiological Studies of Alzheimer Disease
$2,520,781Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2006 · AG
Pulmonary Hypertension Breakthrough Initiative
$2,518,872Mark W Geraci · Indiana University Indianapolis · R24 · FY2016 · HL
Neighborhoods and health across the life course: Early life food security, diet quality, and chemical exposures
$2,518,866Emily Oken · Harvard Pilgrim Health Care, Inc. · UH3 · FY2025 · OD
TAS::75 0872::TAS PROTEOMIC CENTERS: MODIFICATION OF CARDIOVASCULAR PROTEINS BY
$2,516,589Catherine E. Costello · Boston University (Charles River Campus) · N01 · FY2012 · HL